Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TECOGEN INC. Regulatory Filings 2019

Jan 8, 2019

33623_rns_2019-01-08_80886191-36f9-474a-b595-7ba07ca4044a.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 form8-k3rdquarterinvestorp.htm 8-K html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk 1 Copyright 2019 Workiva Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): January 7, 2019 (January 8, 2019)

TECOGEN INC.

(Exact Name of Registrant as Specified in Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-36103 04-3536131
(Commission File Number) (IRS Employer Identification No.)
45 First Avenue
Waltham, Massachusetts 02451
(Address of Principal Executive Offices) (Zip Code)

(781) 622-1120

(Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company þ

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01 Regulation FD Disclosure

On January 8, 2019, Tecogen Inc. (the “Corporation”) will share with investors and potential investors in the Corporation the attached slide presentations titled "3rd Quarter Investor Presentation," and "Emerging Opportunities for Growth," as well as the attached paper titled "Tecogen's Emerging Opportunities for Growth: Cogeneration and Chilling, Indoor Cultivation, and Vehicle Emissions Control." These materials are filed as Exhibits 99.01, 99.02, and 99.03, respectively, to this Current Report on Form 8-K.

The information contained in this item 7.01 and Exhibits 99.01, 99.02, and 99.03 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

The following exhibits relating to Item 7.01 shall be deemed furnished, and not filed:

Exhibit Description

99.01 Presentation titled "3rd Quarter Investor Presentation"

99.02 Presentation titled "Emerging Opportunities for Growth"

99.03 Paper dated January 7, 2019 titled "Tecogen's Emerging Opportunities for Growth: Cogeneration and Chilling, Indoor Cultivation, and Vehicle Emissions Control"

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

By: /s/ Bonnie Brown
January 7, 2019 Bonnie Brown, Principal Financial & Accounting Officer